Giving oral insulin to children at genetic high risk of diabetes stimulates a regulatory immune response without inducing hypoglycaemia, show the findings of the Pre-POINT study. Pre-POINT was a ...
Pre-POINT is a pilot study to determine a suitable dose of oral insulin in children at risk of developing diabetes. The aim of this trial is to induce a protective immune response to islet ...
An international team of researchers from Bristol, Dresden, Munich, Vienna and Denver have successfully completed the first step in the development of an insulin vaccine to prevent type 1 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results